Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform

Contemporaneously Combining Comprehensive Molecular Profiling at Unprecedented Scale with Reference-standard Clinical Data Creates a Novel Platform to Advance Precision Oncology Research IRVING, Texas and CAMBRIDGE, Mass., June 1, 2023 /PRNewswire/ — Caris Life SciencesĀ®(Caris), the…

Click here to view original post